196 related articles for article (PubMed ID: 16223003)
1. [The prognostic value of KI-67 proliferation index in transitional cell carcinoma of renal pelvis and ureter].
Korneev IA
Vopr Onkol; 2005; 51(2):211-5. PubMed ID: 16223003
[TBL] [Abstract][Full Text] [Related]
2. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
[TBL] [Abstract][Full Text] [Related]
4. KI67 proliferation index in tumors of the upper urinary tract as related to established prognostic factors and long-term survival.
Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
Arch Esp Urol; 1998 Mar; 51(2):204-10. PubMed ID: 9586325
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
[TBL] [Abstract][Full Text] [Related]
6. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
8. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
9. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.
Novara G; De Marco V; Dalpiaz O; Galfano A; Bouygues V; Gardiman M; Martignoni G; Patard JJ; Artibani W; Ficarra V
Int J Urol; 2009 Feb; 16(2):187-91. PubMed ID: 19054165
[TBL] [Abstract][Full Text] [Related]
10. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic implication of morphometric stromal parameters of renal pelvis and ureteral transitional cell carcinomas].
Al'-Shukri CKh; Rybakova MG; Makovskaia AI; Tiurin AG; Kozlov VV; Ageev MN; Korneev IA
Urologiia; 2004; (3):10-4. PubMed ID: 15199806
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter.
Masuda M; Iki M; Takano Y; Asakura T; Noguchi S; Ikeda I; Kubota Y; Hosaka M
J Urol; 1996 Jun; 155(6):1877-80; discussion 1880-1. PubMed ID: 8618278
[TBL] [Abstract][Full Text] [Related]
13. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
Cheville JC; Terrell RB; Cohen MB
Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
[TBL] [Abstract][Full Text] [Related]
14. Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival.
Lehmann J; Suttmann H; Kovac I; Hack M; Kamradt J; Siemer S; Wullich B; Zwergel U; Stöckle M
Eur Urol; 2007 May; 51(5):1281-8. PubMed ID: 17125909
[TBL] [Abstract][Full Text] [Related]
15. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF
BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
[TBL] [Abstract][Full Text] [Related]
16. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
Mahnken A; Kausch I; Feller AC; Krüger S
Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373
[TBL] [Abstract][Full Text] [Related]
18. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
[TBL] [Abstract][Full Text] [Related]
19. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.
Rouprêt M; Hupertan V; Sanderson KM; Harmon JD; Cathelineau X; Barret E; Vallancien G; Rozet F
Urology; 2007 Apr; 69(4):656-61. PubMed ID: 17445646
[TBL] [Abstract][Full Text] [Related]
20. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]